1. Response to: 'Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT)': reply from the authors. (1st May 2022) Authors: Cro, S.; Smith, C.H Journal: British journal of dermatology Issue: Volume 186:Number 5(2022) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Response to: 'Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT)': reply from the authors. (2nd March 2022) Authors: Cro, S.; Smith, C.H Journal: British journal of dermatology Issue: Volume 186:Number 5(2022) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗